28
Lipotec’s expertise in molecular cosmetics and biotechnology
Lipotec is presenting two new solutions from its Aimtec™ brand. DELISENS™ offers an innovative mechanism of action directed at treating
several inflammatory and/or pruritogenic skin disorders, decreasing sensations of itching, redness or stinging in sensitive skin while helping to recover its physiological tolerance threshold. It is also recommended to dry-sensitive skin; hydration increased by 34%, compared to placebo, after only one week of applying a cream with 2% DELISENS™
SOLUTION. TELANGYN™ is a tetrapeptide specially developed to treat facial
redness and telangiectasia. The dermatological evaluation showed its efficacy in decreasing erythema intensity by 19.2% or skin redness by 17.7% after applying a cream with 2% TELANGYN™ SOLUTION at the end of a 4-week treatment. From Biointec™
, HYANIFY™
Formulation- enhancing additives
The Dow Chemical Company is featuring a broad range of products from its Dow Personal Care, Dow Microbial Control and Dow Performance Additives businesses. Dow Personal Care is introducing three new technologies; EPITEX™
Surfactants, a new family of plant- based, biodegradable surfactants for use in shampoo and skin cleansing applications. Dow Microbial Control is featuring its wide range of products including paraben-free and formaldehyde-free solutions. Additionally, visitors can learn more about the Dow Microbial Control Customer Application Center offering to customers. Each of Dow Microbial Control’s Customer Application Centers contains dedicated application and challenge testing laboratories with best-in-class equipment, including TAUNOVATE™ High Throughput optimisation. With its globally approved, broad spectrum NEOLONE™
Shine, a hair styling polymer offering outstanding shine in high VOC hairsprays; and EcoSense™
polymer for skin and sun care applications; ACUDYNE™
and KATHON™ Preservatives, Dow
Microbial Control is uniquely positioned to offer high performing actives and formulations designed for personal care and cosmetic applications. Dow Performance Additives has developed application testing that clearly demonstrates the exceptional performance benefits of AMP-ULTRA™ PC Specialty Neutralizer in a range of hair styling formulations. Today’s consumers are on the go and expect their hair products to keep up with their lifestyle. Dow Performance Additives will highlight personal care neutralisers available to maximise the performance of hair styling products, in addition to skin care, eye care and sun care applications.
Dow, Stand Y30 66 Polymer, a water resistant is a biotechnological marine-
based ingredient with excellent hyaluronic acid booster properties, leading to a replenishing effect against dehydration and wrinkles. The mean depth of nasogenian folds decreased by 14.7% in only 14 days of applying a cream containing 1% HYANIFY™
SOLUTION, as showed in vivo. Lipotec, Stand K20
CELLnTEC launches unique in vitro ageing model
CELLnTEC Advanced Cell Systems AG, a life science company specialising in the development of precision in vitro models, has announced the release of VitroAge, a unique model specifically designed to naturally age cells in vitro. Based on a precision culture medium specifically designed to create an ageing environment, the model features natural ageing at a moderate speed, without the need for non-physiological, acute doses of oxidisers or other chemicals. “Traditional cell culture media are a very poor foundation for in vitro ageing studies. With high doses of growth factors and other stimulants, they actively resist the ageing process” said Peter Girling, VP of Business Development at CELLnTEC. “With its precisely designed ageing environment, VitroAge demonstrates many features commonly seen in aged tissues in vivo, including reduced proliferation, decreased longevity, disrupted metabolism, and up- regulated ageing markers”. In recent years, an increasing body of scientific evidence has documented both the central role stem and
progenitor cells play in the ageing process, as well as several related ageing mechanisms observed in many parts of the body. Initial characterisation of the VitroAge model has identified several ageing features previously documented in the scientific literature. With strong support from recent science in the fields of stem cells and ageing, this novel model is ideally suited to both basic researchers investigating ageing, as well as the testing of novel anti-ageing strategies by the personal care industry.
CELLnTEC Advanced Cell Systems, Stand B13
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197